Seizing the opportunity to capitalise on the growing access to HIV treatment to expand HIV prevention

Affiliations

Comment

Helene Gayle et al. Lancet. 2004 Jul.

. 2004 Jul;364(9428):6-8.

doi: 10.1016/S0140-6736(04)16607-5.

¹ HIV, TB & Reproductive Health, Bill & Melinda Gates Foundation, Seattle, WA 98102, USA. heleneg@gatesfoundation.org

No abstract available

Comment in

HIV-1 prevention in the context of increasing access to treatment.
Wilson D, Wichai C, Chamcheun A. Wilson D, et al. Lancet. 2004 Sep 18-24;364(9439):1038. doi: 10.1016/S0140-6736(04)17057-8. Lancet. 2004. PMID: 15380961 No abstract available.

Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost?
Gutierrez JP, Johns B, Adam T, Bertozzi SM, Edejer TT, Greener R, Hankins C, Evans DB. Gutierrez JP, et al. Lancet. 2004 Jul 3-9;364(9428):63-4. doi: 10.1016/S0140-6736(04)16590-2. Lancet. 2004. PMID: 15234857
Scaling up access to antiretroviral treatment in southern Africa: who will do the job?
Kober K, Van Damme W. Kober K, et al. Lancet. 2004 Jul 3-9;364(9428):103-7. doi: 10.1016/S0140-6736(04)16597-5. Lancet. 2004. PMID: 15234864